PATENT CLAIM ANALYSIS

Application Number: 16212056
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "258000"]

Abstract:
The present invention is directed towards the hemisulfate salt of 5,10-methylene-(6R)-tetrahydrofolic acid, preferably in substantially crystalline form, as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.

Claim (Index 19):
A hemisulfate salt of 5,10-methylene-(6R)-tetrahydrofolic acid, which is in a form readily administrable after quick dissolution of said active agent in a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.15625
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15435787', '15869499', '10562200', '14787980', '11702006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8009155052580618
- 35 USC 102 Novelty (BERT): 0.5262837384833634
- Combined Prediction Score: 0.7734523285805919
- Mean Citation Score: 262.70050200000003
- Max Citation Score: 344.9423
- Similarity Product: 253.8746343104243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test